Abacus Life (NASDAQ:ABL) reported quarterly sales of $33.20 million which beat the analyst consensus estimate of $29.76 million by 11.56 percent. This is a 40.40 percent increase over sales of $23.65 million the same period last year.
Abacus Life (NASDAQ:ABL) reported quarterly sales of $33.20 million which beat the analyst consensus estimate of $29.76 million by 11.56 percent. This is a 40.40 percent increase over sales of $23.65 million the same period last year.
Comments